Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Jody Dushay, an endocrinologist and obesity expert at Harvard Medical School
Third-party researchers combining lower doses with behavior change are seeing similar impact
Compounded drugs have not been reviewed by the FDA for safety, efficacy, or manufacturing quality
Janumet (Metformin/Sitagliptin) Janumet 2022 sales: $1.700 billion Company/Developer: Merck Date of first FDA approval: March 30, 2007 Indications Janumet is FDA-approved for: Janumet is a combination of the oral antihyperglycemic drugs sitagliptin and metformin
US$ 23.50
US$ 28.05
US$ 24.23
US$ 22.33
US$ 28.88
US$ 28.62
US$ 25.79
US$ 26.81
